Selank 10mg

Selank is a synthetic heptapeptide developed in Russia as an anxiolytic and nootropic research compound. It is derived from the naturally occurring peptide tuftsin, with structural modifications that improve its stability and duration of action.

Preclinical studies and some human research, primarily conducted in Russia, suggest that Selank may help reduce anxiety, support emotional resilience, enhance certain aspects of learning and memory, and influence immune signaling through the modulation of cytokine expression. Researchers have also investigated its potential effects on neurotransmitter systems, including GABA, serotonin, and dopamine pathways, which may contribute to its observed behavioral effects.

Unlike traditional benzodiazepine medications, available research suggests that Selank does not appear to produce significant sedation, impair cognitive function, or show the same potential for dependence in the studies conducted to date. However, larger, well-controlled clinical trials are still needed to fully establish its long-term safety and effectiveness.

Because high-quality clinical evidence remains limited, Selank is considered an investigational peptide in many countries and has not been approved by major regulatory agencies such as Health Canada or the U.S. FDA for the treatment of anxiety or other medical conditions.

Research Areas of Interest Anxiety and stress response Cognitive performance and memory Emotional resilience Neurotransmitter regulation Immune system signaling through cytokine modulation

Research Use Notice: Selank is intended for laboratory and scientific research purposes only. Current evidence is still evolving, and additional high-quality human studies are needed to better understand its safety profile, mechanisms of action, and potential therapeutic applications.